Gene Network Analysis of PPAR-γ: A Bioinformatics Approach Using STRING

Gene networks present a graphical view at the level of gene activities and genetic functions and help us to understand complex interactions in a meaningful manner. In the present study, we have analyzed the gene interaction of PPAR-γ (peroxisome proliferator-activated receptor gamma) by search tool for retrieval of interacting genes. We find PPAR-γ is highly networked by genetic interactions with 10 genes: RXRA (retinoid X receptor, alpha), PPARGC1A (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha), NCOA1 (nuclear receptor coactivator 1), NR0B2 (nuclear receptor subfamily 0, group B, member 2), HDAC3 (histone deacetylase 3), MED1 (mediator complex subunit 1), INS (insulin), NCOR2 (nuclear receptor co-repressor 2), PAX8 (paired box 8), ADIPOQ (adiponectin) and it augurs well for the fact that obesity and several other metabolic disorders are inter related. Keywords—Gene networks, NCOA1, PPARγ, PPARGC1A, RXRA.

[1]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[2]  Su-Nam Kim,et al.  Regulation of adipocyte differentiation by histone deacetylase inhibitors , 2009, Archives of pharmacal research.

[3]  Roderick Edwards,et al.  Dynamics in high-dimensional model gene networks , 2003, Signal Process..

[4]  Xiaoyan Zhu,et al.  Building Disease-Specific Drug-Protein Connectivity Maps from Molecular Interaction Networks and PubMed Abstracts , 2009, PLoS Comput. Biol..

[5]  T. Osborne,et al.  Peroxisome Proliferator-activated Receptor-γ Coactivator-1α Activation of CYP7A1 during Food Restriction and Diabetes Is Still Inhibited by Small Heterodimer Partner* , 2008, Journal of Biological Chemistry.

[6]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[7]  J. Reddy,et al.  PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex. , 2006, Biochemical and biophysical research communications.

[8]  Chan Wha Kim,et al.  Proteomic and biochemical analyses reveal the activation of unfolded protein response, ERK-1/2 and ribosomal protein S6 signaling in experimental autoimmune myocarditis rat model , 2011, BMC Genomics.

[9]  M. Breyer,et al.  Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. , 2001, Kidney international.

[10]  S. Gabriel,et al.  Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease[S] , 2010, Journal of Lipid Research.

[11]  Michael Müller,et al.  Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance. , 2004, Current opinion in investigational drugs.

[12]  W. Chin,et al.  Ligand and Coactivator Identity Determines the Requirement of the Charge Clamp for Coactivation of the Peroxisome Proliferator-activated Receptor γ* , 2003, The Journal of Biological Chemistry.

[13]  Youping Deng,et al.  Transcriptomic profiles of peripheral white blood cells in type II diabetes and racial differences in expression profiles , 2011, BMC Genomics.

[14]  K. Kristiansen,et al.  The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. , 2002, Developmental cell.

[15]  M. Konopleva,et al.  2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid and Related Compounds Inhibit Growth of Colon Cancer Cells through Peroxisome Proliferator-Activated Receptor γ-Dependent and -Independent Pathways , 2005, Molecular Pharmacology.

[16]  Jun Ren,et al.  Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. , 2007, Current diabetes reviews.

[17]  J. A. Patel,et al.  The role of peroxisome proliferator-activated receptors in human disease , 2006 .

[18]  A. Pugliese,et al.  The insulin gene in diabetes , 2002, Diabetes/metabolism research and reviews.

[19]  Li Wang,et al.  Role of nuclear receptor SHP in metabolism and cancer. , 2011, Biochimica et biophysica acta.

[20]  H. Kadarmideen,et al.  Population and systems genetics analyses of cortisol in pigs divergently selected for stress. , 2007, Physiological genomics.

[21]  R. Roeder,et al.  Alternative Mechanisms by Which Mediator Subunit MED1/TRAP220 Regulates Peroxisome Proliferator-Activated Receptor γ-Stimulated Adipogenesis and Target Gene Expression , 2007, Molecular and Cellular Biology.

[22]  Xian Chen,et al.  Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration. , 2011, Cancer research.

[23]  V. Trovisco,et al.  PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. , 2006, The Journal of clinical endocrinology and metabolism.

[24]  C. Kusminski,et al.  The Road From Discovery to Clinic: Adiponectin as a Biomarker of Metabolic Status , 2009, Clinical pharmacology and therapeutics.

[25]  P. Brazhnik,et al.  Linking the genes: inferring quantitative gene networks from microarray data. , 2002, Trends in genetics : TIG.

[26]  Lisa J. Martin,et al.  The Genes Influencing Adiponectin Levels Also Influence Risk Factors for Metabolic Syndrome and Type 2 Diabetes , 2007, Human biology.

[27]  Christoph Lahtz,et al.  Epigenetic changes of DNA repair genes in cancer. , 2011, Journal of molecular cell biology.

[28]  H. Mewes,et al.  BIOREL: The benchmark resource to estimate the relevance of the gene networks , 2006, FEBS letters.

[29]  Y. Matsuzawa,et al.  Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  N. Maeda,et al.  Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor alpha-regulated gene expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.